CERO
Price
$0.19
Change
-$0.02 (-9.52%)
Updated
Nov 14 closing price
PSTX
Price
$3.21
Change
-$0.07 (-2.13%)
Updated
Nov 14 closing price
111 days until earnings call
Ad is loading...

CERO vs PSTX

Header iconCERO vs PSTX Comparison
Open Charts CERO vs PSTXBanner chart's image
CERo Therapeutics Holdings
Price$0.19
Change-$0.02 (-9.52%)
Volume$12.74M
CapitalizationN/A
Poseida Therapeutics
Price$3.21
Change-$0.07 (-2.13%)
Volume$535.76K
CapitalizationN/A
CERO vs PSTX Comparison Chart
Loading...
CERO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CERO vs. PSTX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERO is a Hold and PSTX is a StrongBuy.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (CERO: $0.19 vs. PSTX: $3.21)
Brand notoriety: CERO and PSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CERO: 36% vs. PSTX: 100%
Market capitalization -- CERO: $28.14M vs. PSTX: $312.86M
CERO [@Biotechnology] is valued at $28.14M. PSTX’s [@Biotechnology] market capitalization is $312.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERO’s FA Score shows that 1 FA rating(s) are green whilePSTX’s FA Score has 0 green FA rating(s).

  • CERO’s FA Score: 1 green, 4 red.
  • PSTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CERO and PSTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERO’s TA Score shows that 6 TA indicator(s) are bullish while PSTX’s TA Score has 5 bullish TA indicator(s).

  • CERO’s TA Score: 6 bullish, 4 bearish.
  • PSTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CERO and PSTX are a good buy in the short-term.

Price Growth

CERO (@Biotechnology) experienced а +165.16% price change this week, while PSTX (@Biotechnology) price change was +9.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.07%. For the same industry, the average monthly price growth was +3.27%, and the average quarterly price growth was +5.23%.

Reported Earning Dates

CERO is expected to report earnings on Mar 24, 2023.

PSTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-2.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PSTX($313M) has a higher market cap than CERO($28.1M). PSTX YTD gains are higher at: -4.464 vs. CERO (-98.298).
CEROPSTXCERO / PSTX
Capitalization28.1M313M9%
EBITDAN/AN/A-
Gain YTD-98.298-4.4642,202%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
CEROPSTX
RSI
ODDS (%)
Bearish Trend 1 day ago
7%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
35%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bullish Trend 1 day ago
21%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
27%
Bullish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
23%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
44%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
12%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
CERO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PSTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CERO and

Correlation & Price change

A.I.dvisor tells us that CERO and GOVX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CERO and GOVX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
-11.66%
GOVX - CERO
31%
Poorly correlated
-3.33%
BRTX - CERO
30%
Poorly correlated
-1.95%
KALV - CERO
27%
Poorly correlated
-6.22%
IMRN - CERO
26%
Poorly correlated
-2.53%
PSTX - CERO
25%
Poorly correlated
-2.13%
More

PSTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PSTX has been loosely correlated with NTLA. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PSTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PSTX
1D Price
Change %
PSTX100%
-2.13%
NTLA - PSTX
49%
Loosely correlated
-6.15%
ALEC - PSTX
47%
Loosely correlated
-4.20%
EDIT - PSTX
46%
Loosely correlated
-6.42%
INZY - PSTX
42%
Loosely correlated
-3.38%
CRSP - PSTX
41%
Loosely correlated
-5.90%
More